{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:31:52Z","timestamp":1794007912268,"version":"4.8.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI166359"],"award-info":[{"award-number":["R01AI166359"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI007172"],"award-info":[{"award-number":["T32AI007172"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002570","name":"American Association of Immunologists","doi-asserted-by":"publisher","award":["5T32HL125241-07"],"award-info":[{"award-number":["5T32HL125241-07"]}],"id":[{"id":"10.13039\/100002570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    causes prolonged infections that disproportionately affect immunocompromised populations. Our understanding of\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    respiratory pathogenesis relies on an acute murine infection model with limited clinical relevance that employs an unnaturally high number of bacteria and requires assessment of bacterial load at 24-36\u2009h post-infection. Here, we demonstrate that low intranasal inoculums in\n                    <jats:italic>tlr4<\/jats:italic>\n                    mutant mice allows for infections lasting at least 3 weeks. Using this \u201cchronic infection model\u201d we determine the adhesin InvL is a virulence factor required during later stages of infection, despite being dispensable in the early phase. We also demonstrate that the chronic model enables distinction between antibiotics that, although initially reduce bacterial burden, either lead to clearance or result in the formation of potential bacterial persisters. To illustrate how our model can be applied to study polymicrobial infections, we inoculate mice with an active\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    infection with\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    or\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    . We find that\n                    <jats:italic>S. aureus<\/jats:italic>\n                    exacerbates infection, while\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    enhances\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    clearance. In all, the chronic model overcomes some limitations of the acute pulmonary model, expanding our capabilities to study\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    pathogenesis and lays the groundwork for the development of similar models for other opportunistic pathogens.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-62655-4","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T13:30:36Z","timestamp":1755264636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections"],"prefix":"10.1038","volume":"16","author":[{"given":"Clay D.","family":"Jackson-Litteken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Di Venanzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-7245","authenticated-orcid":false,"given":"Manon","family":"Janet-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-7547","authenticated-orcid":false,"given":"\u00cdtalo A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Mackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-772X","authenticated-orcid":false,"given":"David A.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-6572","authenticated-orcid":false,"given":"Carolina B.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4497-0976","authenticated-orcid":false,"given":"Mario F.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"62655_CR1","doi-asserted-by":"publisher","first-page":"FSO395","DOI":"10.2144\/fsoa-2018-0127","volume":"5","author":"S Vijayakumar","year":"2019","unstructured":"Vijayakumar, S., Biswas, I. & Veeraraghavan, B. Accurate identification of clinically important Acinetobacter spp.: an update. Future Sci. OA 5, FSO395 (2019).","journal-title":"Future Sci. OA"},{"key":"62655_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/iub.533","volume":"63","author":"GM Cerqueira","year":"2011","unstructured":"Cerqueira, G. M. & Peleg, A. Y. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life 63, 1055\u20131060 (2011).","journal-title":"IUBMB Life"},{"key":"62655_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/pathogens10040387","volume":"10","author":"M Sarshar","year":"2021","unstructured":"Sarshar, M., Behzadi, P., Scribano, D., Palamara, A. T. & Ambrosi, C. Acinetobacter baumannii: an ancient commensal with weapons of a pathogen. Pathogens 10, 387 (2021).","journal-title":"Pathogens"},{"key":"62655_CR4","doi-asserted-by":"crossref","unstructured":"Di Venanzio, G. et al. Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes. Nat. Commun. 10, 2763 (2019).","DOI":"10.1038\/s41467-019-10706-y"},{"key":"62655_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.  Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"62655_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1586\/14787210.2015.1025055","volume":"13","author":"C Dexter","year":"2015","unstructured":"Dexter, C., Murray, G. L., Paulsen, I. T. & Peleg, A. Y. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev. Anti Infect. Ther. 13, 567\u2013573 (2015).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"62655_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1046\/j.1469-0691.2002.00487.x","volume":"8","author":"JM Cisneros","year":"2002","unstructured":"Cisneros, J. M. & Rodriguez-Ba\u00f1o, J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin. Microbiol. Infect. 8, 687\u2013693 (2002).","journal-title":"Clin. Microbiol. Infect."},{"key":"62655_CR8","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","volume":"48","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim, S., Al-Saryi, N., Al-Kadmy, I. M. S. & Aziz, S. N. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol. Biol. Rep. 48, 6987\u20136998 (2021).","journal-title":"Mol. Biol. Rep."},{"key":"62655_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s15010-021-01663-0","volume":"49","author":"S Karakonstantis","year":"2021","unstructured":"Karakonstantis, S. & Kritsotakis, E. I. Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex. Infection 49, 1149\u20131161 (2021).","journal-title":"Infection"},{"key":"62655_CR10","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3892\/etm.2017.4137","volume":"13","author":"D Xiao","year":"2017","unstructured":"Xiao, D. et al. Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: a retrospective analysis. Exp. Ther. Med. 13, 1630\u20131633 (2017).","journal-title":"Exp. Ther. Med."},{"key":"62655_CR11","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1086\/652759","volume":"50","author":"DM Sengstock","year":"2010","unstructured":"Sengstock, D. M. et al. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis. 50, 1611\u20131616 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"62655_CR12","doi-asserted-by":"crossref","unstructured":"Inchai, J. et al. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. J. Intensive Care 3, 9 (2015).","DOI":"10.1186\/s40560-015-0077-4"},{"key":"62655_CR13","doi-asserted-by":"crossref","unstructured":"Giammanco, A., Cal\u00e0, C., Fasciana, T. & Dowzicky, M. J. Global assessment of the activity of tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial. mSphere 2, e00310-16 (2017).","DOI":"10.1128\/mSphere.00310-16"},{"key":"62655_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E., Carrara, E., Savoldi, A., Kattula, D. & Burkert, F. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"62655_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/CCM.0000000000004783","volume":"49","author":"MH Kollef","year":"2021","unstructured":"Kollef, M. H., Torres, A., Shorr, A. F., Martin-Loeches, I. & Micek, S. T. Nosocomial infection. Crit. Care Med. 49, 169\u2013187 (2021).","journal-title":"Crit. Care Med."},{"key":"62655_CR16","doi-asserted-by":"crossref","unstructured":"Jones, R. N. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 51, S81-7 (2010).","DOI":"10.1086\/653053"},{"key":"62655_CR17","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/jac\/dky279","volume":"73","author":"HS Sader","year":"2018","unstructured":"Sader, H. S., Castanheira, M., Mendes, R. E. & Flamm, R. K. Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17). J. Antimicrob. Chemother. 73, 3053\u20133059 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"62655_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/JB.00906-15","volume":"198","author":"BS Weber","year":"2015","unstructured":"Weber, B. S., Harding, C. M. & Feldman, M. F. Pathogenic Acinetobacter: from the cell surface to infinity and beyond. J. Bacteriol. 198, 880\u2013887 (2015).","journal-title":"J. Bacteriol."},{"key":"62655_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/infdis\/jir846","volume":"205","author":"C Kebaier","year":"2012","unstructured":"Kebaier, C. et al. Staphylococcus aureus \u03b1-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J. Infect. Dis. 205, 807\u2013817 (2012).","journal-title":"J. Infect. Dis."},{"key":"62655_CR20","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1128\/IAI.73.4.2504-2514.2005","volume":"73","author":"N Hoffmann","year":"2005","unstructured":"Hoffmann, N. et al. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73, 2504 (2005).","journal-title":"Infect. Immun."},{"key":"62655_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-9118-1_26","volume":"1946","author":"LD Palmer","year":"2019","unstructured":"Palmer, L. D., Green, E. R., Sheldon, J. R. & Skaar, E. P. Assessing Acinetobacter baumannii virulence and persistence in a murine model of lung infection. Methods Mol. Biol. 1946, 289\u2013305 (2019).","journal-title":"Methods Mol. Biol."},{"key":"62655_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-07024-4","volume":"22","author":"JM Pogue","year":"2022","unstructured":"Pogue, J. M., Zhou, Y., Kanakamedala, H. & Cai, B. Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019. BMC Infect. Dis. 22, 36 (2022).","journal-title":"BMC Infect. Dis."},{"key":"62655_CR23","doi-asserted-by":"crossref","unstructured":"Alotaibi, T. et al. Prevalence of multidrug-resistant Acinetobacter baumannii in a critical care setting: a tertiary teaching hospital experience. SAGE Open Med. 9, 20503121211001144 (2021).","DOI":"10.1177\/20503121211001144"},{"key":"62655_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/jac\/dkp056","volume":"63","author":"P Koomanachai","year":"2009","unstructured":"Koomanachai, P., Kim, A. & Nicolau, D. P. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model. J. Antimicrob. Chemother. 63, 982\u2013987 (2009).","journal-title":"J. Antimicrob. Chemother."},{"key":"62655_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/jac\/dkp301","volume":"64","author":"JL Crandon","year":"2009","unstructured":"Crandon, J. L., Kim, A. & Nicolau, D. P. Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. J. Antimicrob. Chemother. 64, 837\u2013839 (2009).","journal-title":"J. Antimicrob. Chemother."},{"key":"62655_CR26","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1128\/AAC.48.8.3127-3129.2004","volume":"48","author":"A Braunstein","year":"2004","unstructured":"Braunstein, A., Papo, N. & Shai, Y. In vitro activity and potency of an intravenously injected antimicrobial peptide and its dl amino acid analog in mice infected with bacteria. Antimicrob. Agents Chemother. 48, 3127 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"62655_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1128\/AAC.41.2.345","volume":"41","author":"ML Joly-Guillou","year":"1997","unstructured":"Joly-Guillou, M. L., Wolff, M., Pocidalo, J. J., Walker, F. & Carbon, C. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob. Agents Chemother. 41, 345 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"62655_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijantimicag.2008.07.008","volume":"33","author":"JY Song","year":"2009","unstructured":"Song, J. Y., Cheong, H. J., Lee, J., Sung, A. K. & Kim, W. J. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Int. J. Antimicrob. Agents 33, 33\u201339 (2009).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"62655_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1099\/jmm.0.060004-0","volume":"62","author":"S Manepalli","year":"2013","unstructured":"Manepalli, S. et al. Characterization of a cyclophosphamide-induced murine model of immunosuppression to study Acinetobacter baumannii pathogenesis. J. Med. Microbiol. 62, 1747\u20131754 (2013).","journal-title":"J. Med. Microbiol."},{"key":"62655_CR30","doi-asserted-by":"crossref","unstructured":"Cochet, F. & Peri, F. The role of carbohydrates in the lipopolysaccharide (LPS)\/toll-like receptor 4 (TLR4) signalling. Int. J. Mol. Sci. 18, 2318 (2017).","DOI":"10.3390\/ijms18112318"},{"key":"62655_CR31","first-page":"59","volume":"667","author":"S Akira","year":"2010","unstructured":"Akira, S. & Yamamoto, M. Lipid A receptor TLR4-mediated signaling pathways. Adv. Exp. Med. Biol. 667, 59\u201368 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"62655_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/oxfordjournals.jbchem.a135294","volume":"98","author":"JY Homma","year":"1985","unstructured":"Homma, J. Y. et al. Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J. Biochem. 98, 395\u2013406 (1985).","journal-title":"J. Biochem."},{"key":"62655_CR33","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 112681 (2014).","journal-title":"Front. Immunol."},{"key":"62655_CR34","doi-asserted-by":"crossref","unstructured":"Lin, L. et al. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. mBio 3, e00312-12 (2012).","DOI":"10.1128\/mBio.00312-12"},{"key":"62655_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1164\/rccm.200505-730OC","volume":"173","author":"S Knapp","year":"2006","unstructured":"Knapp, S. et al. Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J. Respir. Crit. Care Med. 173, 122\u2013129 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"62655_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn8134","volume":"15","author":"JE Hazen","year":"2023","unstructured":"Hazen, J. E., Di Venanzio, G., Hultgren, S. J. & Feldman, M. F. Catheterization triggers resurgent infection seeded by host Acinetobacter baumannii reservoirs. Sci. Transl. Med. 15, eabn8134 (2023).","journal-title":"Sci. Transl. Med."},{"key":"62655_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/jcm.31.3.702-705.1993","volume":"31","author":"L Dijkshoorn","year":"1993","unstructured":"Dijkshoorn, L. et al. Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J. Clin. Microbiol. 31, 702\u2013705 (1993).","journal-title":"J. Clin. Microbiol."},{"key":"62655_CR38","doi-asserted-by":"crossref","unstructured":"Luo, G. et al. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS ONE 7, e29446 (2012).","DOI":"10.1371\/journal.pone.0029446"},{"key":"62655_CR39","doi-asserted-by":"crossref","unstructured":"Behairy, M. Y. et al. Investigation of TLR2 and TLR4 polymorphisms and sepsis susceptibility: computational and experimental approaches. Int. J. Mol. Sci. 23, 10982 (2022).","DOI":"10.3390\/ijms231810982"},{"key":"62655_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcrc.2018.05.012","volume":"47","author":"M Chatzi","year":"2018","unstructured":"Chatzi, M. et al. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece. J. Crit. Care 47, 1\u20138 (2018).","journal-title":"J. Crit. Care"},{"key":"62655_CR41","first-page":"20","volume":"45","author":"L He","year":"2016","unstructured":"He, L. et al. Association of single nucleotide polymorphisms in toll-like receptors with Acinetobacter baumanii infectionin a Chinese population. Iran. J. Public Health 45, 20 (2016).","journal-title":"Iran. J. Public Health"},{"key":"62655_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107128","volume":"146","author":"S-H Wang","year":"2024","unstructured":"Wang, S.-H. et al. The impact and risk factors for developing pneumogenic bacteremia in carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia in the intensive care unit: a multicenter retrospective study. Int. J. Infect. Dis. 146, 107128 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"62655_CR43","doi-asserted-by":"publisher","first-page":"e1011173","DOI":"10.1371\/journal.ppat.1011173","volume":"19","author":"JS Distel","year":"2023","unstructured":"Distel, J. S., Di Venanzio, G., Mackel, J. J., Rosen, D. A. & Feldman, M. F. Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH. PLoS Pathog. 19, e1011173 (2023).","journal-title":"PLoS Pathog."},{"key":"62655_CR44","doi-asserted-by":"publisher","first-page":"e01076","DOI":"10.1128\/mBio.01076-14","volume":"5","author":"AC Jacobs","year":"2014","unstructured":"Jacobs, A. C. et al. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5, e01076\u201314 (2014).","journal-title":"mBio"},{"key":"62655_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab386","volume":"8","author":"N Rakovitsky","year":"2021","unstructured":"Rakovitsky, N. et al. Increased capsule thickness and hypermotility are traits of carbapenem-resistant Acinetobacter baumannii ST3 strains causing fulminant infection. Open Forum Infect. Dis. 8, ofab386 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"62655_CR46","doi-asserted-by":"crossref","unstructured":"Lee, H. H. et al. Depletion of alveolar macrophages increases pulmonary neutrophil infiltration, tissue damage, and sepsis in a murine model of Acinetobacter baumannii pneumonia. Infect. Immun. 88, e00128-20 (2020).","DOI":"10.1128\/IAI.00128-20"},{"key":"62655_CR47","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1128\/IAI.00762-07","volume":"75","author":"H Van Faassen","year":"2007","unstructured":"Van Faassen, H. et al. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun. 75, 5597\u20135608 (2007).","journal-title":"Infect. Immun."},{"key":"62655_CR48","doi-asserted-by":"publisher","first-page":"e40019","DOI":"10.1371\/journal.pone.0040019","volume":"7","author":"H Qiu","year":"2012","unstructured":"Qiu, H. et al. Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS ONE 7, e40019 (2012).","journal-title":"PLoS ONE"},{"key":"62655_CR49","doi-asserted-by":"publisher","first-page":"516.e1","DOI":"10.1016\/j.cmi.2018.12.020","volume":"25","author":"X Zeng","year":"2019","unstructured":"Zeng, X. et al. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice. Clin. Microbiol. Infect. 25, 516.e1\u2013516.e4 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"62655_CR50","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.micinf.2009.06.003","volume":"11","author":"H Qiu","year":"2009","unstructured":"Qiu, H., KuoLee, R., Harris, G. & Chen, W. High susceptibility to respiratory Acinetobacter baumannii infection in A\/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect. 11, 946\u2013955 (2009).","journal-title":"Microbes Infect."},{"key":"62655_CR51","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1128\/IAI.01029-08","volume":"77","author":"H Qiu","year":"2008","unstructured":"Qiu, H., Kuolee, R., Harris, G. & Chen, W. Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice. Infect. Immun. 77, 1015 (2008).","journal-title":"Infect. Immun."},{"key":"62655_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00350-17","volume":"85","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Caspase-11 plays a protective role in pulmonary Acinetobacter baumannii infection. Infect. Immun. 85, e00350-17 (2017).","journal-title":"Infect. Immun."},{"key":"62655_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1348-0421.2011.00402.x","volume":"56","author":"T Tsuchiya","year":"2012","unstructured":"Tsuchiya, T. et al. NK1.1(+) cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia. Microbiol. Immunol. 56, 107\u2013116 (2012).","journal-title":"Microbiol. Immunol."},{"key":"62655_CR54","doi-asserted-by":"publisher","first-page":"890511","DOI":"10.3389\/fcimb.2022.890511","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu, Z. & Xu, W. Neutrophil and macrophage response in Acinetobacter Baumannii infection and their relationship to lung injury. Front. Cell Infect. Microbiol. 12, 890511 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"62655_CR55","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fmicb.2015.01134","volume":"6","author":"LM Grguric-Smith","year":"2015","unstructured":"Grguric-Smith, L. M. et al. Neutropenia exacerbates infection by Acinetobacter baumannii clinical isolates in a murine wound model. Front. Microbiol. 6, 1134 (2015).","journal-title":"Front. Microbiol."},{"key":"62655_CR56","first-page":"1296","volume":"211","author":"KW Bruhn","year":"2015","unstructured":"Bruhn, K. W. et al. Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia. J. Infect. Dis. 211, 1296\u20131305 (2015).","journal-title":"J. Infect. Dis."},{"key":"62655_CR57","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/IAI.00069-11","volume":"79","author":"JM Breslow","year":"2011","unstructured":"Breslow, J. M. et al. Innate immune responses to systemic acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect. Immun. 79, 3317\u20133327 (2011).","journal-title":"Infect. Immun."},{"key":"62655_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-55","volume":"6","author":"AF Zuluaga","year":"2006","unstructured":"Zuluaga, A. F. et al. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6, 55 (2006).","journal-title":"BMC Infect. Dis."},{"key":"62655_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594540","volume":"11","author":"ZC Ding","year":"2021","unstructured":"Ding, Z. C., Aboelella, N. S., Bryan, L., Shi, H. & Zhou, G. The monocytes that repopulate in mice after cyclophosphamide treatment acquire a neutrophil precursor gene signature and immunosuppressive activity. Front. Immunol. 11, 594540 (2021).","journal-title":"Front. Immunol."},{"key":"62655_CR60","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1172\/JCI28139","volume":"116","author":"X Zhang","year":"2006","unstructured":"Zhang, X., Shan, P., Jiang, G., Cohn, L. & Lee, P. J. Toll-like receptor 4 deficiency causes pulmonary emphysema. J. Clin. Invest. 116, 3050\u20133059 (2006).","journal-title":"J. Clin. Invest."},{"key":"62655_CR61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1203\/01.pdr.0000246071.50268.51","volume":"60","author":"V Sampath","year":"2006","unstructured":"Sampath, V. et al. Altered postnatal lung development in C3H\/HeJ mice. Pediatr. Res.60, 663\u2013668 (2006).","journal-title":"Pediatr. Res."},{"key":"62655_CR62","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1128\/IAI.05913-11","volume":"80","author":"KA Brossard","year":"2012","unstructured":"Brossard, K. A. & Campagnari, A. A. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun. 80, 228\u2013233 (2012).","journal-title":"Infect. Immun."},{"key":"62655_CR63","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/21505594.2016.1262313","volume":"8","author":"A P\u00e9rez","year":"2017","unstructured":"P\u00e9rez, A. et al. The FhaB\/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain. Virulence 8, 959\u2013974 (2017).","journal-title":"Virulence"},{"key":"62655_CR64","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2741\/e801","volume":"9","author":"SDA Astaneh","year":"2017","unstructured":"Astaneh, S. D. A., Rasooli, I. & Gargari, S. L. M. Filamentous hemagglutinin adhesin FhaB limits A. baumannii biofilm formation. Front. Biosci.9, 266\u2013275 (2017).","journal-title":"Front. Biosci."},{"key":"62655_CR65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.micpath.2014.07.007","volume":"74","author":"S Darvish Alipour Astaneh","year":"2014","unstructured":"Darvish Alipour Astaneh, S., Rasooli, I. & Mousavi Gargari, S. L. The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606(T). Micro Pathog. 74, 42\u201349 (2014).","journal-title":"Micro Pathog."},{"key":"62655_CR66","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1128\/JB.06769-11","volume":"194","author":"LV Bentancor","year":"2012","unstructured":"Bentancor, L. V., Camacho-Peiro, A., Bozkurt-Guzel, C., Pier, G. B. & Maira-Litr\u00e1n, T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. J. Bacteriol. 194, 3950\u20133960 (2012).","journal-title":"J. Bacteriol."},{"key":"62655_CR67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/21505594.2018.1558693","volume":"10","author":"M Weidensdorfer","year":"2019","unstructured":"Weidensdorfer, M. et al. The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii. Virulence 10, 68\u201381 (2019).","journal-title":"Virulence"},{"key":"62655_CR68","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1007\/s00203-021-02343-1","volume":"203","author":"R Hatefi Oskuei","year":"2021","unstructured":"Hatefi Oskuei, R., Darvish Alipour Astaneh, S. & Rasooli, I. A conserved region of Acinetobacter trimeric autotransporter adhesion, Ata, provokes suppression of Acinetobacter baumannii virulence. Arch. Microbiol. 203, 3483\u20133493 (2021).","journal-title":"Arch. Microbiol."},{"key":"62655_CR69","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1021\/acsinfecdis.1c00021","volume":"7","author":"G Tram","year":"2021","unstructured":"Tram, G. et al. The Acinetobacter baumannii autotransporter adhesin Ata recognizes host glycans as high-affinity receptors. ACS Infect. Dis. 7, 2352\u20132361 (2021).","journal-title":"ACS Infect. Dis."},{"key":"62655_CR70","doi-asserted-by":"publisher","first-page":"e48830","DOI":"10.1371\/journal.pone.0048830","volume":"7","author":"M Ishikawa","year":"2012","unstructured":"Ishikawa, M., Nakatani, H. & Hori, K. AtaA, a new member of the trimeric autotransporter adhesins from Acinetobacter sp. Tol 5 mediating high adhesiveness to various abiotic surfaces. PLoS ONE 7, e48830 (2012).","journal-title":"PLoS ONE"},{"key":"62655_CR71","doi-asserted-by":"publisher","first-page":"e0025822","DOI":"10.1128\/mbio.00258-22","volume":"13","author":"CD Jackson-Litteken","year":"2022","unstructured":"Jackson-Litteken, C. D. et al. InvL, an invasin-like adhesin, is a type II secretion system substrate required for Acinetobacter baumannii uropathogenesis. mBio 13, e0025822 (2022).","journal-title":"mBio"},{"key":"62655_CR72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2217\/fmb-2021-0216","volume":"17","author":"C Yesil","year":"2022","unstructured":"Yesil, C. et al. Use of colistin with rifampicin, trimethoprim-sulfamethoxazole and teicoplanin in Acinetobacter mouse infection model. Future Microbiol. 17, 665\u2013671 (2022).","journal-title":"Future Microbiol."},{"key":"62655_CR73","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s10096-023-04674-x","volume":"42","author":"F \u0130zci","year":"2023","unstructured":"\u0130zci, F. et al. The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model. Eur. J. Clin. Microbiol. Infect. Dis. 42, 1365\u20131372 (2023).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"62655_CR74","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000356755","volume":"59","author":"G Dinc","year":"2014","unstructured":"Dinc, G. et al. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis. Chemotherapy 59, 325\u2013329 (2014).","journal-title":"Chemotherapy"},{"key":"62655_CR75","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1128\/AAC.01678-08","volume":"53","author":"AM Nicasio","year":"2009","unstructured":"Nicasio, A. M., Crandon, J. L. & Nicolau, D. P. In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and klebsiella pneumoniae isolates. Antimicrob. Agents Chemother. 53, 2756 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"62655_CR76","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/jac\/46.5.827","volume":"46","author":"J ML","year":"2000","unstructured":"ML, J., Wolff, M., Farinotti, R., Bryskier, A. & Carbon, C. In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia. J. Antimicrob. Chemother. 46, 827\u2013830 (2000).","journal-title":"J. Antimicrob. Chemother."},{"key":"62655_CR77","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1179\/1973947813Y.0000000074","volume":"25","author":"AM Queenan","year":"2013","unstructured":"Queenan, A. M., Davies, T. A., He, W. & Lynch, A. S. Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients. J. Chemother. 25, 141\u2013147 (2013).","journal-title":"J. Chemother."},{"key":"62655_CR78","doi-asserted-by":"publisher","first-page":"e0271021","DOI":"10.1128\/spectrum.02710-21","volume":"10","author":"LA Al-Madboly","year":"2022","unstructured":"Al-Madboly, L. A. A novel triple combination to combat serious infections with carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. Microbiol. Spectr. 10, e0271021 (2022).","journal-title":"Microbiol. Spectr."},{"key":"62655_CR79","doi-asserted-by":"publisher","first-page":"e02585","DOI":"10.1128\/AAC.02585-17","volume":"62","author":"AD Kang","year":"2018","unstructured":"Kang, A. D. et al. Efficacy of apramycin against multidrug-resistant Acinetobacter baumannii in the murine neutropenic thigh model. Antimicrob. Agents Chemother. 62, e02585\u201317 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"62655_CR80","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cmi.2020.12.004","volume":"27","author":"K Becker","year":"2021","unstructured":"Becker, K. et al. Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice. Clin. Microbiol. Infect. 27, 1315\u20131321 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"62655_CR81","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1093\/jac\/dkac225","volume":"77","author":"C Zhao","year":"2022","unstructured":"Zhao, C. et al. Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose. J. Antimicrob. Chemother. 77, 2718 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"62655_CR82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/CMR.00058-16","volume":"30","author":"D Wong","year":"2016","unstructured":"Wong, D. et al. Clinical and pathophysiological overview of acinetobacter infections: a century of challenges. Clin. Microbiol. Rev. 30, 409 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"62655_CR83","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1469-0691.2005.01227.x","volume":"11","author":"ML Joly-Guillou","year":"2005","unstructured":"Joly-Guillou, M. L. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 11, 868\u2013873 (2005).","journal-title":"Clin. Microbiol. Infect."},{"key":"62655_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.601614","volume":"11","author":"Y Sato","year":"2020","unstructured":"Sato, Y., Tansho-Nagakawa, S., Ubagai, T. & Ono, Y. Analysis of immune responses in Acinetobacter baumannii-infected klotho knockout mice: a mouse model of Acinetobacter baumannii infection in aged hosts. Front. Immunol. 11, 601614 (2020).","journal-title":"Front. Immunol."},{"key":"62655_CR85","doi-asserted-by":"publisher","first-page":"e00591","DOI":"10.1128\/IAI.00591-19","volume":"87","author":"G Harris","year":"2019","unstructured":"Harris, G., Holbein, B. E., Zhou, H., Howard Xu, H. & Chen, W. Potential mechanisms of mucin-enhanced Acinetobacter baumannii virulence in the mouse model of intraperitoneal infection. Infect. Immun. 87, e00591\u201319 (2019).","journal-title":"Infect. Immun."},{"key":"62655_CR86","doi-asserted-by":"publisher","first-page":"e100727","DOI":"10.1371\/journal.pone.0100727","volume":"9","author":"W Huang","year":"2014","unstructured":"Huang, W. et al. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PLoS ONE 9, e100727 (2014).","journal-title":"PLoS ONE"},{"key":"62655_CR87","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jac\/15.4.441","volume":"15","author":"Y Obana","year":"1985","unstructured":"Obana, Y., Nishino, T. & Tanino, T. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 15, 441\u2013448 (1985).","journal-title":"J. Antimicrob. Chemother."},{"key":"62655_CR88","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.vaccine.2017.01.060","volume":"35","author":"FL Yang","year":"2017","unstructured":"Yang, F. L. et al. A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate. Vaccine 35, 1440\u20131447 (2017).","journal-title":"Vaccine"},{"key":"62655_CR89","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.1073\/pnas.1523116113","volume":"113","author":"MS Bhuiyan","year":"2016","unstructured":"Bhuiyan, M. S. et al. Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. Proc. Natl. Acad. Sci. USA 113, 9599\u20139604 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62655_CR90","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imm.12972","volume":"155","author":"H Tomlin","year":"2018","unstructured":"Tomlin, H. & Piccinini, A. M. A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens. Immunology 155, 186\u2013201 (2018).","journal-title":"Immunology"},{"key":"62655_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.003","volume":"312","author":"TN Wight","year":"2017","unstructured":"Wight, T. N. et al. Interplay of extracellular matrix and leukocytes in lung inflammation. Cell Immunol. 312, 1 (2017).","journal-title":"Cell Immunol."},{"key":"62655_CR92","doi-asserted-by":"publisher","first-page":"e0249300","DOI":"10.1371\/journal.pone.0249300","volume":"16","author":"Y Onishi","year":"2021","unstructured":"Onishi, Y. et al. Clinical features of acute fibrinous and organizing pneumonia: an early histologic pattern of various acute inflammatory lung diseases. PLoS ONE 16, e0249300 (2021).","journal-title":"PLoS ONE"},{"key":"62655_CR93","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1513\/pats.201112-053AW","volume":"9","author":"HA Chapman","year":"2012","unstructured":"Chapman, H. A. Epithelial responses to lung injury. Proc. Am. Thorac. Soc. 9, 89\u201395 (2012).","journal-title":"Proc. Am. Thorac. Soc."},{"key":"62655_CR94","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jprot.2018.02.027","volume":"189","author":"E \u00c5hrman","year":"2018","unstructured":"\u00c5hrman, E. et al. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. J. Proteom. 189, 23\u201333 (2018).","journal-title":"J. Proteom."},{"key":"62655_CR95","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1164\/rccm.201204-0754OC","volume":"186","author":"AJ Booth","year":"2012","unstructured":"Booth, A. J. et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am. J. Respir. Crit. Care Med. 186, 866\u2013876 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"62655_CR96","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1183\/09031936.00192611","volume":"40","author":"R Annoni","year":"2012","unstructured":"Annoni, R. et al. Extracellular matrix composition in COPD. Eur. Respir. J. 40, 1362\u20131373 (2012).","journal-title":"Eur. Respir. J."},{"key":"62655_CR97","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1513\/AnnalsATS.201406-240MG","volume":"12","author":"ES White","year":"2015","unstructured":"White, E. S. Lung extracellular matrix and fibroblast function. Ann. Am. Thorac. Soc. 12, S30\u2013S33 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"62655_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2014.01.011","volume":"34","author":"MY Chang","year":"2014","unstructured":"Chang, M. Y. et al. A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol. 34, 1\u201312 (2014).","journal-title":"Matrix Biol."},{"key":"62655_CR99","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1369\/0022155415610383","volume":"63","author":"JM Snyder","year":"2015","unstructured":"Snyder, J. M., Washington, I. M., Birkland, T., Chang, M. Y. & Frevert, C. W. Correlation of versican expression, accumulation, and degradation during embryonic development by quantitative immunohistochemistry. J. Histochem. Cytochem. 63, 952\u2013967 (2015).","journal-title":"J. Histochem. Cytochem."},{"key":"62655_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01866-5","volume":"9","author":"H Niu","year":"2024","unstructured":"Niu, H., Gu, J. & Zhang, Y. Bacterial persisters: molecular mechanisms and therapeutic development. Signal Transduct. Target. Ther. 9, 1\u201332 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"62655_CR101","doi-asserted-by":"publisher","first-page":"7116","DOI":"10.1128\/AEM.02636-13","volume":"79","author":"TK Wood","year":"2013","unstructured":"Wood, T. K., Knabel, S. J. & Kwan, B. W. Bacterial persister cell formation and dormancy. Appl. Environ. Microbiol. 79, 7116 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"62655_CR102","doi-asserted-by":"publisher","first-page":"12958","DOI":"10.3389\/bjbs.2024.12958","volume":"81","author":"AP Kunnath","year":"2024","unstructured":"Kunnath, A. P., Suodha Suoodh, M., Chellappan, D. K., Chellian, J. & Palaniveloo, K. Bacterial persister cells and development of antibiotic resistance in chronic infections: an update. Br. J. Biomed. Sci. 81, 12958 (2024).","journal-title":"Br. J. Biomed. Sci."},{"key":"62655_CR103","doi-asserted-by":"publisher","first-page":"e0033822","DOI":"10.1128\/msystems.00338-22","volume":"7","author":"G Li","year":"2022","unstructured":"Li, G. et al. Essential fitness repertoire of Staphylococcus aureus during co-infection with Acinetobacter baumannii in vivo. mSystems 7, e0033822 (2022).","journal-title":"mSystems"},{"key":"62655_CR104","doi-asserted-by":"publisher","first-page":"ycae077","DOI":"10.1093\/ismeco\/ycae077","volume":"4","author":"S Timme","year":"2024","unstructured":"Timme, S. et al. Competitive inhibition and mutualistic growth in co-infections: deciphering Staphylococcus aureus-Acinetobacter baumannii interaction dynamics. ISME Commun. 4, ycae077 (2024).","journal-title":"ISME Commun."},{"key":"62655_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36252-2","volume":"14","author":"L Semenec","year":"2023","unstructured":"Semenec, L. et al. Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence. Nat. Commun. 14, 702 (2023).","journal-title":"Nat. Commun."},{"key":"62655_CR106","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12866-019-1621-5","volume":"19","author":"R Krasauskas","year":"2019","unstructured":"Krasauskas, R., Skerni\u0161kyt\u0117, J., Armalyt\u0117, J. & Su\u017eied\u0117lien\u0117, E. The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system. BMC Microbiol. 19, 241 (2019).","journal-title":"BMC Microbiol."},{"key":"62655_CR107","doi-asserted-by":"publisher","first-page":"e0138265","DOI":"10.1371\/journal.pone.0138265","volume":"10","author":"GD Repizo","year":"2015","unstructured":"Repizo, G. D. et al. Differential role of the T6SS in Acinetobacter baumannii Virulence. PLoS ONE 10, e0138265 (2015).","journal-title":"PLoS ONE"},{"key":"62655_CR108","doi-asserted-by":"publisher","first-page":"9442","DOI":"10.1073\/pnas.1502966112","volume":"112","author":"BS Weber","year":"2015","unstructured":"Weber, B. S., Ly, P. M., Irwin, J. N., Pukatzki, S. & Feldman, M. F. A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii. Proc. Natl. Acad. Sci. USA 112, 9442\u20139447 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62655_CR109","doi-asserted-by":"publisher","first-page":"e1007969","DOI":"10.1371\/journal.ppat.1007969","volume":"16","author":"D Storey","year":"2020","unstructured":"Storey, D. et al. Klebsiella pneumoniae type VI secretion system-mediated microbial competition is PhoPQ controlled and reactive oxygen species dependent. PLoS Pathog. 16, e1007969 (2020).","journal-title":"PLoS Pathog."},{"key":"62655_CR110","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","volume":"7","author":"CJY Tsai","year":"2016","unstructured":"Tsai, C. J. Y., Loh, J. M. S. & Proft, T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7, 214\u2013229 (2016).","journal-title":"Virulence"},{"key":"62655_CR111","doi-asserted-by":"publisher","first-page":"e0141623","DOI":"10.1128\/mbio.01416-23","volume":"14","author":"JC McGuffey","year":"2023","unstructured":"McGuffey, J. C. et al. The tRNA methyltransferase TrmB is critical for Acinetobacter baumannii stress responses and pulmonary infection. mBio 14, e0141623 (2023).","journal-title":"mBio"},{"key":"62655_CR112","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-1119(98)00130-9","volume":"212","author":"TT Hoang","year":"1998","unstructured":"Hoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J. & Schweizer, H. P. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212, 77\u201386 (1998).","journal-title":"Gene"},{"key":"62655_CR113","doi-asserted-by":"crossref","unstructured":"Pontes, M. H. & Groisman, E. A. Slow growth dictates non-heritable antibiotic resistance in Salmonella enterica. Sci. Signal. 12, eaax3938 (2019).","DOI":"10.1126\/scisignal.aax3938"},{"key":"62655_CR114","doi-asserted-by":"publisher","first-page":"e00066","DOI":"10.1128\/AEM.00066-19","volume":"85","author":"K Ducas-Mowchun","year":"2019","unstructured":"Ducas-Mowchun, K. et al. Next generation of Tn 7-based single-copy insertion elements for use in multi- and pan-drug-resistant strains of Acinetobacter baumannii. Appl. Environ. Microbiol. 85, e00066\u201319 (2019).","journal-title":"Appl. Environ. Microbiol."},{"key":"62655_CR115","doi-asserted-by":"publisher","first-page":"e00360","DOI":"10.1128\/mBio.00360-13","volume":"4","author":"CM Harding","year":"2013","unstructured":"Harding, C. M. et al. Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility. mBio 4, e00360\u201313 (2013).","journal-title":"mBio"},{"key":"62655_CR116","doi-asserted-by":"publisher","first-page":"e59388","DOI":"10.1371\/journal.pone.0059388","volume":"8","author":"MD Carruthers","year":"2013","unstructured":"Carruthers, M. D., Nicholson, P. A., Tracy, E. N. & Munson, R. S. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS ONE 8, e59388 (2013).","journal-title":"PLoS ONE"},{"key":"62655_CR117","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mimet.2010.07.002","volume":"82","author":"A Kumar","year":"2010","unstructured":"Kumar, A., Dalton, C., Cortez-Cordova, J. & Schweizer, H. P. Mini-Tn7 vectors as genetic tools for single copy gene cloning in Acinetobacter baumannii. J. Microbiol. Methods 82, 296\u2013300 (2010).","journal-title":"J. Microbiol. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62655-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:45:32Z","timestamp":1757393132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62655"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62655-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7617"}}